Inhibition of trimethadione and dimethadione teratogenicity by the cyclooxygenase inhibitor acetylsalicylic acid: A unifying hypothesis for the teratologic effects of hydantoin anticonvulsants and structurally related compounds
- 1 March 1989
- journal article
- research article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 97 (3) , 406-414
- https://doi.org/10.1016/0041-008x(89)90245-7
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Pharmacological studies on the potentiation of phenytoin teratogenicity by acetaminophenTeratology, 1986
- GENETIC PREDISPOSITION TO PHENYTOIN-INDUCED BIRTH DEFECTSThe Lancet, 1985
- Studies on 5,5-diphenylhydantoin irreversible binding to rat liver microsomal proteinsBiochemical Pharmacology, 1982
- Assessment of the teratogenic potential of trimethadione in the CD-1 mouseToxicology and Applied Pharmacology, 1979
- Metabolism and Disposition of Trimethadione in Pregnant RatsEpilepsia, 1979
- Dimethadione-induced fetotoxicity in ratsToxicology, 1978
- Fetal trimethadione syndromeTeratology, 1978
- Teratogenic effects of trimethadione and dimethadione in the chick embryo*1Toxicology and Applied Pharmacology, 1974
- Trimethadione and human teratogenesisTeratology, 1970
- A study of the product of demethylation of trimethadione in the control of petit mal epilepsyNeurology, 1965